Differential effects of Bcl-2 overexpression on fibre outgrowth and survival of "embryonic dopaminergic neurons in intracerebral transplants

European Journal of Neuroscience

Volumn 11, Issue 9, 1999, Pages 3073-3081

  Schierle, Gabriele S ^a   Leist, Marcel ^b   Martinou, Jean Claude ^c   Widner, Håkan ^a   Nicotera, Pierluigi ^b   Brundin, Patrik ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

Apoptosis; Intracerebral transplantation; Mouse; Parkinson's disease; Rat

Indexed keywords

CASPASE INHIBITOR; DNA FRAGMENT; LACTATE DEHYDROGENASE; PROTEIN BCL 2; STAUROSPORINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CAUSE OF DEATH; CELL DEATH; CELL LOSS; CELL SURVIVAL; CELL SUSPENSION; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EMBRYO; EMBRYO CELL; ENZYME ACTIVATION; GENE EXPRESSION; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MESENCEPHALON; MOUSE; NERVE FIBER; NERVE GRAFT; NERVE TRANSPLANTATION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; TRANSGENE; XENOGRAFT;

EID: 0032880090     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1999.00727.x     Document Type: Article

References (61)

1. Anton, R., Kordower, J.H., Kane, D.J., Markham, C.H. & Bredesen, D.E. (1995) Neural transplantation of cells expressing the anti-apoptotic gene bcl-2. Cell Transplant., 4, 49-54.
2. Barkats, M., Nakao, N., Grasbon-Frodl, E.M., Bilang-Bleuel, A., Revah, F., Mallet, J. & Brundin, P. (1997) Intrastriatal grafts of embryonic mesencephalic rat neurons genetically modified using an adenovirus encoding human Cu/Zn superoxide dismutase. Neuroscience, 78, 703-713.
3. Björklund, L., Spenger, C. & Strömberg, I. (1997) Tirilazad mesylate increases dopaminergic neuronal survival in the in oculo grafting model. Exp. Neurol., 148, 324-333.
4. Brundin, P., Nilsson, O.G., Gage, F.H. & Björklund, A. (1985) Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons. Exp. Brain Res., 60, 204-208.
5. Brundin, P., Duan, W.-M. & Sauer, H. (1994) Functional effects of mesencephalic dopamine neurons and adrenal chromaffin cells grafted to the rodent striatum. In Dunnett, S.B. & Björklund, A. (eds), Functional Neural Transplantation. Raven Press, New York, pp. 9-46.
6. Chen, D.F., Schneider, G.E., Martinou, J.C. & Tonegawa, S. (1997) Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature, 385, 434-139.
7. Cheng, E.H., Kirsch, D.G., Clem, R.J., Ravi, R., Kastan, M.B., Bedi, A., Ueno, K. & Hardwick, J.M. (1997) Conversion of Bcl-2 to a Bax-like death effector by caspases. Science, 278, 1966-1968.
8. Coyle, J.T. & Puttfarcken, P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science, 262, 689-695.
9. Duan, W.-M., Widner, H. & Brundin, P. (1995) Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats. Exp. Brain Res., 104, 227-242.
10. Dubois-Dauphin, M., Frankowski, H., Tsujimoto, Y., Huarte, J. & Martinou, J.-C. (1994) Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc. Natl Acad. Sci. USA, 91, 3309-3313.
11. Ellerby, L.M., Ellerby, H.M., Park, S.M., Holleran, A.L., Murphy, A.N., Fiskum, G., Kane, D.J., Testa, M.P., Kayalar, C. & Bredesen, D.E. (1996) Shift of the cellular oxidation-reduction potential in neural cells expressing bcl-2. J. Neurochem., 67, 1259-1267.
12. Farlie, P.G., Dringen, R., Rees, S.M., Kannourakis, G. & Bernard, O. (1995) bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc. Natl Acad. Sci. USA, 92, 4397-4401.
13. Grandgirard, D., Studer, E., Monney, L., Belser, T., Fellay, I., Borner, C. & Michel, M.R. (1998) Alphaviruses induce apoptosis in Bcl-2 overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. EMBO J., 17, 1268-1278.
14. Granholm, A.C., Mott, J.L., Bowenkamp, K., Eken, S., Henry, S., Hoffer, B.J., van Lapchak, P.A., Palmer, M.R., Home, C. & Gerhardt, G.A. (1997) Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp. Brain Res., 116, 29-38.
15. Hengartner, M.O. & Horvitz, H.R. (1994) C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell, 76, 665-676.
16. Herdegen, T., Claret, F.X., Kallunki, T., Martin-Villalba, A., Winter. C., Hunter, T. & Karin, M. (1998) Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J. Neurosci., 18, 5124-5135.
17. Hockenbery, D.M., Oltavi, Z.N., Yin, X.-M., Milliman, C.L. & Korsmeyer, S.J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75, 241-251.
18. Kane, D.J., Sarafian, T.A., Anton, R., Hahn, H., Gralla, E.B., Valentine, J.S., Ord, T. & Bredesen, D.E. (1993) Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science, 262, 1274-1277.
19. Kane, D.J., Ord, T., Anton, R. & Bredesen, D.E. (1995) Expression of bcl-2 inhibits necrotic neural cell death. J. Neurosci. Res., 40, 269-275.
20. Karlsson, J., Emgård, M., Rosenblad, C. & Brundin, P. (1998) Treatment with the spin-trap agent a-phenyl-tert-butyl nitrone does not enhance the survival of embryonic or adult dopamine neurons. Brain Res., 805, 155-168.
21. Kroemer, G. (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med., 3, 614-620.
22. Kruman, I., Bruce-Keller, A.J., Bredesen, D., Waeg, G. & Mattson, M.P. (1997) Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci., 17, 5089-5100.
23. Lawrence, M.S., Ho, D.Y., Sun, G.H., Steinberg, G.K. & Sapolsky, R.M. (1996) Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J. Neurosci., 16, 486-496.
24. Leist, M. & Nicotera, P. (1998) Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res., 239, 183-201.
25. Le-Niculescu, H., Bonfoco, E., Kasuya, Y., Claret, F.X., Green, D.R. & Karin, M. (1999) Following withdrawal of survival factors activation of the JNK pathway in neuronal cells results in Fas ligand induction leading to cell death. Mol. Cell Biol., 19, 751-763.
26. Owens, G.P. (1994) Programmed cell death in developing grafts of fetal substantia nigra. Exp. Neurol., 129, 27-36.
27. Martinou, J.-C., Dubois-Dauphin, M., Staple, J.K., Rodriguez, I., Frankowski, H., Missotten, M., Albertini, P., Talabot, D., Catsicas, S., Pietra, C. & Huarte, J. (1994) Overexpression of Bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron, 13, 1017-1030.
28. Mattson, M.P. (1998) Free radicals, calcium, and the synaptic plasticity-cell death continuum: emerging roles of the transcription factor NF kappa B. Int. Rev. Neurobiol., 42, 103-168.
29. Mayer, E., Fawcett, J.W. & Dunnett, S.B. (1993) Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons-II. Effects on nigral transplants in vivo. Neuroscience, 56, 389-398.
30. Nakao, N., Frodl, E.M., Duan, W.-M., Widner, H. & Brundin, P. (1994) Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl Acad. Sci. USA, 91, 12408-12412.
31. Nakao, N., Frodl, E.M., Widner, H., Carlson, E., Eggerding, F.A., Epstein, C.J. & Brundin, P. (1995) Overexpressing Cu/ZN superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nature Med., 1, 226-231.
32. Nicotera, P., Leist, M. & Manzo, L. (1999) Neuronal cell death: a demise with different shapes. Trends Pharmacol. Sci., 20, 46-51.
33. Offen, D., Beart, P.M., Cheung, N.S., Pascoe, C.J., Hochman, A., Gorodin, S., Melamed, E., Bernard, R. & Bernard, O. (1998) Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Proc. Natl Acad. Sci. USA, 95, 5789-5794.
34. Oh, J.H., Choi, W.S., Kim, J.E., Seo, J.W., O'Malley, K.L. & Oh, Y.J. (1998) Overexpression of HA-Bax but not Bcl-2 or Bel-XL attenuates 6-hydroxydopamine-induced neuronal apoptosis. Exp. Neurol., 154, 193-198.
35. O'Malley, E.K., Black, I.E. & Dreyfus, C.F. (1991) Local support cells promote survival of substantia nigra dopaminergic neurons in culture. Exp. Neurol., 112, 40-48.
36. Pettmann, B. & Hendersen, C.E. (1998) Neuronal cell death. Neuron, 20, 633-647.
37. Reed, J.C. (1997) Double identity for proteins of the Bcl-2 family. Nature, 387, 773-776.
38. Rosenblad, C., Martinez-Serrano, A. & Björklund, A. (1996) Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience, 75, 979-985.
39. Sadoul, R. (1998) Bcl-2 family members in the development and degenerative pathologies of the nervous system. Cell Death Differ., 5, 805-815.
40. Sauer, H. & Brundin, P. (1991) Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Restor. Neurol. Neurosci., 2, 123-135.
41. Sautter, J., Tseng, J.L., Braguglia, D., Aebischer, P., Spenger, C., Seiler, R.W., Widmer, H.R. & Zurn, A.D. (1998) Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts. Exp. Neurol., 149, 230-236.
42. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K.J., Debatin, K.M., Krammer, P.H. & Peter, M.E. (1998) Two CD95 (Apo-1/ Fas) signaling pathways. EMBO J., 17, 1675-1687.
43. Schierle, G.S., Hansson, O., Leist, M., Nicotera, P., Widner, H. & Brundin, P. (1999) Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nature Med., 5, 97-100.
44. Schmidt, R.H., Björklund, A., Stenevi, U., Dunnett, S.B. & Gage, F.H. (1983) Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. Acta Physiol. Scand. Suppl., 522, 19-28.
45. Schulze-Osthoff, K., Krammer, P.H. & Dröge, W. (1994) Divergent signalling via Apo-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J., 13, 4587-4596.
46. Shimizu, S., Eguchi, Y., Kamiike, W., Waguri, S., Uchiyama, Y., Matsuda, H. & Tsujimoto, Y. (1996) Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene, 12, 2045-2050.
47. Sinclair, S.R., Svendsen, C.N., Torres, E.M., Martin, D., Fawcett, J.W. & Dunnett, S.B. (1996) GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. Neuroreport, 7, 2547-2552.
48. Tabbal, S., Fahn, S. & Frucht, S. (1998) Fetal tissue transplantation in Parkinson's disease. Curr. Opin. Neurol., 11, 341-349.
49. Takayama, H., Ray, J., Raymon, H.K., Baird, A., Hogg, J., Fisher, L.J. & Gage, F.H. (1995) Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nature Med., 1, 53-58.
50. Takeshima, T., Johnston, J.M. & Commissiong, J.W. (1994) Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J. Neurosci., 14, 4769-4779.
51. Tamatani, M., Ogawa, S. & Tohyama, M. (1998) Roles of Bcl-2 and caspases in hypoxia-induced neuronal cell death: a possible neuroprotective mechanism of peptide growth factors. Brain Res. Mol. Brain Res., 58, 27-39.
52. Tanabe, H., Eguchi, Y., Kamada, S., Martinou, J.-C. & Tsujimoto, Y. (1997) Susceptibility of cerebellar granule neurons derived from Bcl-2 deficient and transgenic mice to cell death. Eur. J. Neurosci., 9, 848-856.
53. Vanhaesebroeck, B., Reed, J.C., De Valck, D., Grooten, J., Miyashita, T., Van Tanaka, S., Beyaert, R., Roy, F. & Fiers, W. (1993) Effect of bcl-2 protooncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity. Oncogene, 8, 1075-1081.
54. Wang, H.G., Rapp, U.R. & Reed, J.C. (1996) Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell, 87, 629-638.
55. Wang, H.G. & Reed, J.C. (1998) Mechanisms of Bcl-2 function. Histol. Histopathol., 13, 521-530.
56. West, M.J., Slomianka, L. & Gundersen, H.J. (1991) Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec., 231, 482-497.
57. Yang, L., Matthews, R.T., Schulz, J.B., Klockgether, T., Liao, A.W., Martinou, J.-C., Penney, J.B. Jr, Hyman, B.T. & Beal, M.F. (1998) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing bcl-2. J. Neurosci., 18, 8145-8152.
58. Yurek, D.M., Lu, W., Hipkens, S. & Wiegand, S.J. (1996) BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp. Neurol., 137, 105-118.
59. Zawada, W.M., Zastrow, D.J., Clarkson, E.D., Adams, F.S., Bell, K.P. & Freed, C.R. (1998) Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res., 786, 96-103.
60. Zhong, L.T., Sarafian, T., Kane, D.J., Charles, A.C., Mah, S.P., Edwards, R.H. & Bredesen, D.E. (1993) bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl Acad. Sci. USA, 90, 4533-4537.
61. Zeng, B.Y., Jenner, P. & Marsden, C.D. (1996) Altered motor function and graft survival produced by basic fibroblast growth factor in rats with 6-OHDA lesions and fetal ventral mesencephalic grafts are associated with glial proliferation. Exp. Neurol., 139, 214-226.